Your browser doesn't support javascript.
loading
Effective variant filtering and expected candidate variant yield in studies of rare human disease.
Pedersen, Brent S; Brown, Joe M; Dashnow, Harriet; Wallace, Amelia D; Velinder, Matt; Tristani-Firouzi, Martin; Schiffman, Joshua D; Tvrdik, Tatiana; Mao, Rong; Best, D Hunter; Bayrak-Toydemir, Pinar; Quinlan, Aaron R.
Afiliação
  • Pedersen BS; Department of Human Genetics, University of Utah, Salt Lake City, UT, USA. bpederse@gmail.com.
  • Brown JM; Department of Human Genetics, University of Utah, Salt Lake City, UT, USA.
  • Dashnow H; Department of Human Genetics, University of Utah, Salt Lake City, UT, USA.
  • Wallace AD; Department of Human Genetics, University of Utah, Salt Lake City, UT, USA.
  • Velinder M; Department of Human Genetics, University of Utah, Salt Lake City, UT, USA.
  • Tristani-Firouzi M; Department of Pediatrics, University of Utah, Salt Lake City, UT, USA.
  • Schiffman JD; Division of Pediatric Hematology/Oncology, Center for Children's Cancer Research, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • Tvrdik T; School of Medicine, Emory University, Atlanta, GA, USA.
  • Mao R; Department of Pathology, University of Utah, Salt Lake City, UT, USA.
  • Best DH; ARUP Institute for Clinical and Experimental Pathology, ARUP Laboratories, Salt Lake City, UT, USA.
  • Bayrak-Toydemir P; Department of Pediatrics, University of Utah, Salt Lake City, UT, USA.
  • Quinlan AR; School of Medicine, Emory University, Atlanta, GA, USA.
NPJ Genom Med ; 6(1): 60, 2021 Jul 15.
Article em En | MEDLINE | ID: mdl-34267211
ABSTRACT
In studies of families with rare disease, it is common to screen for de novo mutations, as well as recessive or dominant variants that explain the phenotype. However, the filtering strategies and software used to prioritize high-confidence variants vary from study to study. In an effort to establish recommendations for rare disease research, we explore effective guidelines for variant (SNP and INDEL) filtering and report the expected number of candidates for de novo dominant, recessive, and autosomal dominant modes of inheritance. We derived these guidelines using two large family-based cohorts that underwent whole-genome sequencing, as well as two family cohorts with whole-exome sequencing. The filters are applied to common attributes, including genotype-quality, sequencing depth, allele balance, and population allele frequency. The resulting guidelines yield ~10 candidate SNP and INDEL variants per exome, and 18 per genome for recessive and de novo dominant modes of inheritance, with substantially more candidates for autosomal dominant inheritance. For family-based, whole-genome sequencing studies, this number includes an average of three de novo, ten compound heterozygous, one autosomal recessive, four X-linked variants, and roughly 100 candidate variants following autosomal dominant inheritance. The slivar software we developed to establish and rapidly apply these filters to VCF files is available at https//github.com/brentp/slivar under an MIT license, and includes documentation and recommendations for best practices for rare disease analysis.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: NPJ Genom Med Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: NPJ Genom Med Ano de publicação: 2021 Tipo de documento: Article